I’m not a doomsayer—but when a virus jumps from birds to cows to humans, I pay attention. H5N1 is now infecting mammals and has crossed into people. Governments are already stockpiling vaccines. In this piece, I break down the biotech companies preparing for what could become the next pandemic—and why a few under-the-radar stocks could soar if things escalate.